Digitalna platforma ima za cilj da konkretne inovacije i tehnološka rešenja, proizvedena od strane akademske i istraživačke zajednice, učini dostupnim privatnim kompanijama. Ovo je usluga za automatsko preuzimanje, sinhronizaciju, sortiranje i prikazivanje informacija sa velikih naučnih platformi kao što su Academia.edu, Google Scholar ili Researchers Gate sa platforme EmpowerHR4Inno. Platforma se inicijalno fokusira na prioritetne sektore, prehrambenu industriju, zdravstveni turizam, horizontalni IT prioritet i nacionalno proizvedena rešenja sa tendencijom daljeg razvoja. Sljedeće informacije se mogu naći:
  • Biblioteka kurseva sa objavljenim podsadržajem VoS-a, rezultatima, drugim rešenjima i digitalnim alatima i HR modelima;
  • Skup funkcija koje omogućavaju slanje novijih, objavljenih članaka, radova korisnicima koji se registruju kao zainteresovani za određenu grupu vesti.
Oxford University Press (OUP)
Trends in oesophageal cancer mortality in Montenegro, 1990–2018
Abstract Background Oesophageal cancer (OC) is a significant public health issue, despite the decreasing trends in OC mortality rates observed globally in the past decades. The objective of our study is to analyze the pattern of OC mortality in Montenegro between 1990 and 2018 and contribute to the development of a national long-term strategy for the prevention and control of this malignancy. Methods...
Preuzmite dokument 2024 Marina Jaksic , Mirjana Nedović Vuković , Zoran Bukumirić , Miloš Lukić , Brigita Smolović
Ovid Technologies (Wolters Kluwer Health)
Colorectal cancer mortality trend analysis in Montenegro from 1990 to 2018
Colorectal cancer (CRC) is the second leading cause of cancer-related death in Europe. This study aimed to investigate CRC mortality trends in Montenegro from 1990 to 2018 and critically review the impact of preventive activities on cancer suppression in this country. We used the national CRC mortality data categorized by sex and age. Mortality rates were age-standardized according to the World Standard Population. The trends were described using regression techniques. In the period from 1990 to...
Preuzmite dokument 2024 Marina Jaksic , Mirjana Nedović Vuković , Mileta Golubović , Brigita Smolović , Dragan Lausevic
Ovid Technologies (Wolters Kluwer Health)
Time trends in liver cancer mortality rates in Montenegro from 1990 to 2018
Objective Liver cancer is the third most common cause of cancer-related deaths worldwide. Hepatitis B and C infections are the main factors affecting mortality. During recent years, Montenegro conducted activities on eradication of viral hepatitis according to the global strategy for the primary prevention of liver cancer mortality. The objective of this study was to assess the liver cancer mortality trend in Montenegro for the period of 1990–2018 using regression techniques....
Preuzmite dokument 2024 Marina Jaksic , Danijela Stojanović , Mirjana Nedović Vuković , Brigita Smolović
American Association for Cancer Research (AACR)
The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic Cancer
AbstractThe relationship between diabetes mellitus (DM) and pancreatic cancer is complex—DM is both a risk factor and early sign of pancreatic cancer. DM is a risk factor for pancreatic cancer because it increases insulin resistance, intrapancreatic concentrations of insulin, and the bioavailability of IGF, subsequently promoting ductal cell proliferation. Accordingly, treatment targeting the insulin/IGF pathway is the focus of many researchers. Antidiabetic drugs modify the risk for pancreatic...
Preuzmite dokument 2023 Ljiljana Vučković , Katarina Popovic , Milica Martinović , Brigita Smolović
Wiley
First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19
AbstractBackground and AimsTocilizumab (TCZ; interleukine‐6 receptor antagonist) has been proposed to treat severe forms of Coronavirus disease‐19 (COVID‐19) because interleukine‐6 plays an important role in COVID‐19‐induced cytokine storm. Several clinical studies have shown very good effects of TCZ in patients with COVID‐19, with a few minor side effects reported. Only eight serious liver injuries caused by TCZ were reported before being used in the treatment of patients with COVID‐19. Considering...
Preuzmite dokument 2020 Marina Ratković , Jelena Bojović , Ana Bulatović , Brigita Smolović , Ranko Lazović , Damir Muhović , Batrić Vukčević
  • Previous
  • 1 (current)
  • Next
Partneri
Pretplatite se na repozitorijum